Triple Therapy with Exenatide/Pioglitazone/Metformin vs. Conventional Therapy: Changes in Liver Fibrosis Scores after 2 Years of Treatment in Patients with New-Onset Type 2 Diabetes Mellitus
Abstract
Source: Metabolism - Clinical and Experimental - Category: Biomedical Science Authors: Olga Lavrynenko, Muhammad Abdul-Ghani, Mariam Alatrach, Curtiss Puckett, John Adams, Naim Alkhouri, Ralph DeFronzo Source Type: research
More News: Actos | Biomedical Science | Byetta | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Fortamet | Liver | Metformin | Urology & Nephrology